Table 2. Outcomes according to the different treatment modalities.
| Outcomes | LE group, n (%) | FD group, n (%) | OR | 95% CI | Adjusted P value |
|---|---|---|---|---|---|
| Complete occlusion† | 27/30 (90.0) | 14/23 (60.9) | 5.79 | 1.35–24.85 | 0.01* |
| Adequate occlusion† | 28/30 (93.3) | 20/23 (87.0) | 0.98 | 0.09–10.83 | 0.98 |
| In-stent stenosis/thrombosis‡ | 2/30 (6.7) | 3/23 (13.0) | 0.43 | 0.04–4.16 | 0.46 |
| General neurological complications in the corresponding vascular territories§ | 8/55 (14.5) | 5/36 (13.9) | 0.32 | 0.05–2.05 | 0.22 |
| Neurological complications in the corresponding vascular territories within 30 days after the procedure§ | 5/55 (9.1) | 4/36 (11.1) | 0.61 | 0.08–4.64 | 0.63 |
| Unfavorable outcome§ | 6/55 (10.9) | 4/36 (11.1) | 0.07 | 0.01–1.26 | 0.07 |
| Complication-related mortality§ | 4/55 (7.3) | 3/36 (8.3) | 0.24 | 0.02–3.79 | 0.31 |
*, P<0.05; LE, low-profile visualized intraluminal support-within-Enterprise overlapping-stent technique; FD, flow diversion; OR, odds ratio; CI, confidence interval. †, adjusted for aneurysm maximal diameter, age, and aneurysm involving the basilar artery; ‡, adjusted for patient presenting with ischemic symptoms, age, and hypertension; §, adjusted for patient presenting with ischemic symptoms, unilateral vertebral artery sacrifice, aneurysm involving the basilar artery, age, and aneurysm maximal diameter.